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bstract
It has long been established that an adverse maternal condition impacts on the developing fetus and predisposes the offspring to develop metabolic
nd cardiovascular disease in later life. However, the underlying mechanisms that are initiated during development and contribute to the disease
redisposition are understudied. Recently, epigenetic reprogramming in early life has emerged as a promising candidate that could cause altered
NA transcription and gene expression into adulthood and contribute to disease susceptibility. This review will focus on the impact of maternal high
at diet to the offspring in early life and the adult health consequences. We will then discuss the current literature supporting a role for epigenetic
odification, such as DNA methylation and histone modifications, as a key mechanism underlying developmental programming.
 2013 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  The  developmental  origins  hypothesis
The “developmental origins of adult disease” hypothesis orig-
nated from epidemiological studies conducted by David Barker
nd colleagues in Hertfordshire, England in 1989. They found
hat being born small for gestational age was a major risk fac-
or for the development of cardiovascular disease later in life
ith significantly increased the risk of mortality from heart fail-
re [1,2]. These studies were the first of many epidemiological
nd animal studies that have rigorously investigated the impact
f altered fetal, early postnatal and childhood growth on the
evelopment of later life diseases. Indeed, it is now unequivo-
ally accepted that early life insults increase the susceptibility
f the offspring to developing a plethora of adverse condi-
ions in later life including, but not limited to, type 2 diabetes
3–5], insulin resistance [4–8], hypertension [1] and osteoporo-
is [9,10]. These early life insults to the offspring primarily
riginate from an adverse maternal condition prior to and/or
uring pregnancy, such as gestational diabetes, obesity, exces-
ive weight gain, pre-eclampsia, smoking, undernutrition and
teroplacental insufficiency. Each of these abnormal conditions
mposes negative impact on the gestational milieu and leads to
mportant consequences for the growth and development of the
etus and health of the offspring in adulthood.Early life origins of later life disease is often referred to as
programming’. Defined by Hales and Barker, ‘programming’ is
he “permanent or long term change in the structure or function
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f an organism resulting from a stimulus or insult acting at a crit-
cal period of early life” [11]. Furthermore, the adult outcomes
f early life ‘programming’ are characterized by the nature of
he insult and developmental responses, the timing in which the
nsult occurs, and the duration of the insult [12,13]. The insult
ost adversely affects the organs that undergo rapid growth
n the offspring at the time of the insult occurring. Another
henomenon that likely contributes to early life programming
vents is the “predictive adaptive response”. This occurs when
he fetus undergoes or initiates adaptations during gestation or
arly postnatal development based on the predicted postnatal
utritional environment [14–16]. For example, poor nutritional
onditions during gestation may trigger metabolic adaptations
n the fetus in preparation for poor nutrition after birth in order
o ensure survival. However, if the resultant postnatal nutrition
s abundant, then the programmed metabolic adaptations that
ccurred in  utero  will become detrimental and likely result in
xcess energy storage, altered postnatal growth, altered body
omposition (e.g.  increased fat mass:lean mass) and subsequent
etabolic dysfunction in later life [11,12,17].
The remainder of this review will primarily focus on 2 impor-
ant and relevant questions: (1) the impact of maternal obesity
nd/or high fat diet during gestation on the development of
etabolic disease in the adult offspring; and (2) the role of epi-
enetic modifications as the underlying mechanism responsible
or the developmental programming of later disease. Although
evelopmental programming is a well-established phenomenon,
uch of the literature is concerned with the impact of maternal
ndernutrition and uteroplacental insufficiency that often result
n small birth weight and later life disease. However, it is becom-
ng more apparent that the correlation between birth weight and
ater disease is presented with a U shaped curve; and being
orn large for gestational age is also a significant risk factor for
ater disease [18–20]. Furthermore, maternal obesity and high-
at diet are increasing in prevalence and the impact on offspring
ealth warrants attention. Epigenetics is a relatively new field of
esearch that is primarily concerned with the regulation of gene
ranscription through modifications of DNA structure, such as
NA methylation and histone methylation/acetylation. Changes
n epigenetic regulation have been shown to occur in early life
evelopment in response to environmental cues and unveils new
ossibilities in the programming field as to the long-term impact
nd mechanistic insight into developmental programming.
.  Maternal  obesity/high  fat  feeding
The prevalence of maternal obesity is increasing at an alarm-
ng rate [21], however, the consequences for the health of the
ffspring in later life is poorly understood compared with that
f fetal undernutrition and fetal growth restriction. In various
xperimental models including sheep and rodents, offspring of
bese mothers, or mothers exposed to a high-fat diet gener-
lly exhibit increased birth weight and fat mass [22–28]. Other
eports showed no changes in birth weight [29–37] possibly due
o differences of the animal models and experimental designs.
urthermore the severity, length and timing of maternal high-
at feeding and the postnatal growth profile of the offspring
l
m
i
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ay also contribute to the interpretation of offspring health
utcomes. In later life, offspring of obese or high-fat fed moth-
rs are more susceptible to developing non-alcoholic fatty liver
isease [30,38], insulin resistance [39,40], glucose intolerance
24,25,39,40], obesity [25,39,40], hyperphagia [25], hyperten-
ion [25,32,41] and cardiovascular impairments [25,32,41].
issue-specific alterations in gene expression and organ devel-
pment in early life, induced by obesity related maternal factors
hat alter the gestational milieu, likely have impact on tissue
unction throughout the life span.
Fetal nutrient supply during gestation is dependent on both
aternal nutritional status and the transfer of those nutrients
cross the placenta. Obesity and high-fat diet are often associ-
ted with elevated circulating lipids, inflammation and insulin
esistance. During pregnancy, obesity and high-fat diet result
n significantly increased lipid transfer across the placenta and
xposure of the fetus to lipids at an earlier stage of gestation than
ormal [42]. The early and increased lipid exposure is likely aug-
ented by elevated gene and protein expression of the placental
atty acid transporters (FATP1, FATP4 and CD36), which has
een reported in obese pregnant ewes at 75 and 135 d of gestation
term = 145 d)[42]. Indeed, elevated free fatty acids, triglyceri-
es and cholesterol were also observed in the placenta and in
he plasma of the fetus [28]. Lipid species are able to activate
ell signaling pathways and act as ligands for nuclear receptors.
herefore, increased circulating lipids in the fetal circulation has
he potential to alter gene expression during development and
ay play a role in the cellular signaling processes responsible
or increased susceptibility of later disease.
Elevated circulating lipids are associated with widespread
nflammation in obese conditions [43]. In obese pregnant ewes,
levated lipids in the placenta was associated with activation
f inflammatory signaling pathways of c-Jun N-terminal kinase
JNK/c-jun) and nuclear factor kappa-light-chain-enhancer of
ctivated B cells (NF-B) via  activation of the Toll-like recep-
or 4 (TLR4) of which free fatty acids are known ligands [28].
ctivation of inflammatory signaling was also associated with
ncreased levels of pro-inflammatory cytokines including tumor
ecrosis factor-  (TNF-), interleukin (IL)-1, IL-6, IL-8 and
L-18 mRNA in the placenta [28]. Importantly, similar findings
ere reported in obese human mothers along with macrophage
ccumulation in the placenta [23]. It is likely that the inflam-
atory factors and resulting oxidative stress cues within the
lacenta of obese mothers can be transferred to the fetus and
ctivate/repress important signaling events resulting in abnor-
al development [23,28]. However, to date few studies have
nvestigated the impact of maternal or placental inflammation
n offspring development and later health. One study showed
hat inflammation during pregnancy had a significant adverse
mpact on the development of the fetal brain and nervous sys-
em [44], which could contribute to behavioral and cognitive
rregularities and conditions such as autism, schizophrenia, cere-
ral palsy, blindness and mental retardation. It is, therefore,
ikely that a maternal obesity-induced inflammatory environ-
ent would contribute to maladaptive programming events
n other fetal organs/tissues. Indeed, inflammation has been
hown to impair myogenic differentiation and skeletal muscle
R.C. Laker et al. / Food Science and H
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Fig. 1. Flow diagram summarizing the characteristics of obesity/high fat diet
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pathways. However, not all studies have reported impaired mus-uring pregnancy and the impact on the developing fetus that may contribute to
aladaptation and adverse health outcomes in adult offspring.
evelopment [45,46], while promoting adipogenesis possibly
hrough alterations in NF-B signaling [26,47]. Therefore,
aternal-fetal inflammation represents an important mechanism
ikely responsible for alterations in the developmental gene
rogram and abnormal growth leading to increased disease sus-
eptibility later in life. The impact of maternal obesity/high fat
iet to offspring during development and consequences in later
ife are summarized in Fig. 1.
.  Offspring  metabolic  outcomes  of  maternal
besity/high-fat  feeding
.1.  Liver
The fetal liver is particularly vulnerable to changes of mater-
al nutritional status since nutrients that cross the placenta into
he fetal circulation are first shuttled to the liver. In obese preg-
ancies, the liver is directly exposed to elevated lipid levels with
onsequential lipid accumulation and alterations of metabolism
nd gene expression. Buckley et al. [22] reported that maternal
igh-fat feeding led to elevated liver triglycerides in conjunc-
ion with reduced insulin signaling proteins (∼50% reduction
n insulin receptor ) in rat offspring at 3 months of age along
ith a subtle impairment of whole body metabolic phenotype
22]. Another study demonstrated in rats that long-term mater-
al high-fat feeding resulted in accumulation of lipid vacuoles
n hepatocytes of 36 weeks old offspring and demonstrated a
atty liver phenotype [41]. Furthermore, elevations in serum C
eactive protein (CRP) were reported in the female offspring of
igh-fat fed mothers suggesting a role for inflammation in fetal
rogramming [41]. The mechanism by which inflammation in
he mother/fetus causes adverse liver adaptation and later life
c
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ealth consequences is yet to be fully elucidated and warrants
urther investigation.
.2.  Skeletal  muscle
Skeletal muscle plays a major role in whole body insulin
ensitivity since it is responsible for about 80% of insulin stimu-
ated glucose disposal in the body [48]. Skeletal muscle deficits
hat contribute to whole body metabolic dysfunction include
eductions in muscle mass (fat:lean mass ratio) and insulin resis-
ance, both of which have been observed in offspring exposed to
n abnormal gestational milieu. In models of fetal undernutri-
ion, impaired skeletal muscle development has been observed
n early life [32,49,50] with functional consequences for mus-
le strength later in life [49,51,52]. In the mouse, offspring of
bese mothers have reduced muscle mass [25], which is likely
 consequence of reduced fiber number [36,47] and/or reduced
ber size [26,36,47]. The underlying mechanisms for this abnor-
al muscle development may be altered transcriptional control
f the myogenic regulatory factors (MRFs) that are critical for
uscle cell specification and differentiation. One study reported
educed expression of myogenic differentiation 1 (MyoD) and
yogenin, in fetal sheep at day 75 of gestation in mothers fed an
besogenic diet during pregnancy [26]. MyoD and myogenin are
wo MRFs responsible for muscle cell lineage specification and
ifferentiation. Therefore, reduced expression of these factors
ould lead to reduced number of myogenic cells and ultimately
esult in lower muscle mass in fully developed animals. This
ay have significant negative impact on metabolic disease in
dulthood, especially in the face of increased metabolic demand
uch as occurs with high-fat diet and/or aging.
Programmed impairments in skeletal muscle metabolism,
uch as changes in the insulin signaling pathway also con-
ribute to the adult metabolic phenotype. For example, Jensen
nd colleagues showed that adult humans with low birth
eight had impaired insulin-stimulated phosphatidylinositol 3-
inase (PI3K)/Akt activation in skeletal muscle [53]. Others
ave shown reduced expression of key proteins in the insulin-
ignaling pathway in skeletal muscle in adult humans [54,55]
nd rodents [55] that were born small. Similarly, overnutrition
n pregnant ewes [27,56] and high-fat feeding in rodents [57]
lso resulted in reduced skeletal muscle PI3K activity associated
ith altered insulin receptor substrate-1 (IRS-1) serine phos-
horylation. Another critical regulator of cellular metabolism is
he AMP-activated protein kinase (AMPK) which is an energy-
ensing molecule and when activated increases fat oxidation and
lucose utilization in the muscle improving insulin sensitivity
nd glucose uptake [58]. Indeed, Zhu and colleagues reported
educed AMPK signaling and impaired development of skele-
al muscle in fetuses of obese ewes [27]. Taken together, these
ata suggest that offspring exposed to an abnormal gestational
nvironment are susceptible to reduced skeletal muscle sub-
trate utilization mediated by impairments in multiple signalingle metabolism in offspring exposed to maternal over-nutrition.
uckley and colleagues reported increased expression of insulin
ignaling proteins in the quadriceps muscle as well as normal
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etabolic phenotype in 3 months old rat offspring born to moth-
rs fed a diet high in polyunsaturated fats [22]. Nevertheless,
heir finding was accompanied by increased total body fat and
bdominal fat as well as reduced lean mass [22], which would
ikely result in metabolic dysfunction later in life. The elevated
nsulin signaling proteins in the muscle may be compensating
or the overall metabolic imbalance, which may not be sustained
ith age.
The programming of skeletal muscle mass and metabolism
n offspring exposed to obese pregnancies is likely related to
etal inflammation and inflammatory signaling in the muscle
uring development. For example, the reduced expression of
yoD and myogenin in the fetal sheep, as discussed above,
ere accompanied by increased NF-B signaling in the skeletal
uscle [26]. Others have reported elevated skeletal muscle NF-
B signaling associated with insulin resistance and increased
ntramuscular adipocytes in late gestation fetuses of obese ewes
36]. Finally, Zhu et al. reported increased TNF-  in the fetal
irculation and increased oxidative stress in the muscle of off-
pring of over-nourished ewes, implicating inflammation as a
otential mediator of developmental programming [27].
In summary, obesity and/or high-fat diet during gestation and
arly life significantly contributes to metabolic dysfunction in
he offspring both in early life and in adulthood when a disease
henotype is often more apparent. Although lipid accumulation
nd inflammation in offspring appears to be consistently asso-
iated with maternal obesity and high-fat feeding, there has yet
o be a definitive mechanism identified to confirm a causative
ole. Currently, the leading mechanistic candidate responsible
or early life programming of later disease is epigenetic mod-
fications induced by a maternal insult that is maintained into
dulthood, resulting in altered gene transcription and functional
onsequences of abnormal metabolic phenotype.
.  Epigenetic  mechanisms
Epigenetic modifications are structural changes that occur
o the DNA without changing the DNA sequence and can
esult in altered gene expression [59–63]. Epigenetic modifi-
ations of genes have been implicated in the development of
any human diseases, including cancers [64–66], neurologi-
al disorders [67,68] and type 2 diabetes [69–72]. The most
ell described epigenetic modifications are DNA methylation
f cytosine residues within cytosine-guanine dinucleotides (CpG
slands), and histone modifications with methylation and acety-
ation of the lysine residues in the N-terminal tail of core histones
f the chromatin structure. More recently, microRNA regula-
ion of gene expression has also been identified as a mechanism
esponsible for epigenetic modifications and evidence suggests
icroRNAs may play a role in regulation of DNA methyla-
ion [73,74]. These epigenetic marks, particularly if they are
ear the promoter regions of functional genes, can influence
ranscription by altering access of transcriptional machinery to
he DNA. DNA methylation may occur through recruitment
f Methyl-CpG binding domain proteins (MBDs), while his-
one modifications can change chromatin confirmation between
pen and closed states, resulting in altered availability of DNA
t
a
a
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or transcription. In the past, epigenetic regulation was believed
o occur exclusively during germ cell development and in pre-
mplantation embryos and to be sustained throughout the life
pan [75,76]; however, it is now apparent that epigenetic events
an occur in response to a variety of environmental cues through-
ut life and are not necessarily permanent modifications [75,76].
Recent evidence supports a role for altered epigenetic reg-
lation to occur in the fetus in response to changes of the
estational milieu [77–82]. Abnormal epigenetic regulation may
mpact on transcriptional control of functionally important genes
uring development as well as in later life, contributing to
bnormal function and disease susceptibility. During periods of
issue/organ development, cells are rapidly dividing and repli-
ating DNA, making the genome more prone to epigenetic
egulation. The timing of the maternal insult may have tissue-
pecific consequences due to timed tissue development. Stable
hanges to the epigenome and consequent alterations in gene
ranscription during early embryogenesis may result in changes
o stem cell lineage specification, in the rate and number of mito-
is and/or apoptosis, in the expression of structural proteins and
f the metabolic and homeostatic control processes. Any one
r combination of these consequences could cause permanent
eficits in organ structure and function and represent a major
ealth burden for the offspring in later life. Table 1 summa-
izes the current literature reporting on epigenetic modifications
n different models of developmental programming and their
bserved or predicted impact on later metabolic health of the
ffspring.
Another complicating factor in epigenetic research is that
NA methylation and histone modifications can interact with
nd influence each other [59,83,84]. These interactions are not
ell understood and add an additional layer of complexity in elu-
idating the mechanism underlying the functional consequences
f early programming events. For the purposes of this review,
NA methylation and histone modifications will be addressed
ndividually and their interactions will not be considered. The
ollowing sections will focus on the existing research in devel-
pmental programming of gene and tissue-specific epigenetic
arks that provide insight into the potential underlying mecha-
isms of later metabolic disease.
.1.  DNA  methylation
Methylation of DNA primarily occurs on the 5′ position of
ytosine bases within CpG dinucleotide pairs, resulting in the
ormation of 5-methylcytosine. This event is mediated by the
NA methyltransferases (DNMT 1, 3a and 3b). DNMT3a and
b are primarily responsible for de  novo  methylation events [85],
hich are maintained following mitosis by DNMT1 [86]. The
ajor regulators of DNMT activity are not well defined; how-
ver, the leading candidates include microRNA regulation [87]
nd phosphorylation of the DNMT targeting domain [88,89] as
ell as other post-translational modifications [90]. Changes inranslational activation and protein degradation of DNMTs can
lso contribute to their abundance and hence total enzymatic
ctivity. Depending on the region of the gene where the methyla-
ion occurs, gene transcription can be silenced by the recruitment
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Table 1
Summary of literature showing maternal induced epigenetic modifications in the offspring that may have consequences for the development of metabolic disease in adulthood.
Citation Experimental model Offspring tissue and age Gene and epigenetic modification Gene expression and potenial health
outcomes
Burdge et al. [99] 9% protein diet throughout
pregnancy in Wistar rats.
F1 and F2 male offspring liver at 80 d
of age.
Glucocorticoid receptor and PPAR
promoter regions hypomethylated.
Trend (P < 0.1) for higher mRNA of GR and
PPAR and downstream targets acyl-CoA
oxidase and phosphoenolpyruvate
carboxykinase (PEPCK; P < 0.5). Predicts
increased gluconeogenesis, metabolic
dysfunction and transgenerational
transmission.
Burdge et al. [100] 25% increase in dietary energy at
conception through to F3 generation
in Wistar rats.
F1, F2 and F3 female offspring liver
at 70 d of age.
PEPCK CpG site specific hyper- and
hypomethylation in experimental
groups.
PEPCK mRNA was higher in experimental
group and inversely related to methylation
level of CpGs in promoter
Gemma et al. [101] Small and large for gestational age
humans.
Umbilical cord DNA at birth. Positive correlation between
maternal BMI and PGC-1  promoter
methylation.
No association between offspring
characteristics and methylation status.
Brøns et al. [70] Healthy young men of low birth
weight (LBW) with or without 5 d
high fat diet.
Young adult males skeletal muscle. PGC-1 hypermethylated in LBW
with control diet only.
LBW men showed insulin resistance and
decreased PGC-1  and oxidative
phosphorylation gene expression following 5
days high fat diet. PGC-1  methylation did
not correlate with mRNA expression.
Hoile et al. [123] Female Wistar rats fed low (3%) or
high (21%) diet content of butter or
fish oil (FO).
Male and female offspring liver at
77 d of age.
Hypermethylation of Fads2 with high
dietary content of butter or FO with
FO higher than butter.
Fads2 mRNA correlated negatively with
Fads2 promoter methylation levels. Predict
contributes to regulation of PUFA synthesis
in adulthood.
Lillycrop et al. [81] 50% Protein restricted diet thoughout
pregnancy in Wistar rats.
Offspring liver at 34 d of age. Glucocorticoid receptor promoter
hypomethylated. Histone H3 and H4
acetylation increased.
Increased GR gene expression. Predict
contributes to metabolic phenotype.
Raychaudhuri et al. [108] 50% food restriction from mid
gestation to weaning in Sprague
Dawley rats.
Female offspring skeletal muscle at 2
and 450 d of age.
GLUT4 histone modifications
causing co-repressor formation. No
change in DNA methylation.
Reduced GLUT4 protein and gene
expression in adulthood of female offspring.
Zheng et al. [109] 50% food restriction throughout
gestation in Sprague Dawley rats.
Female offspring skeletal muscle at
38 d of age.
C/EBP  promoter region
hyperacetylation of histones H3 and
H4.
Increased gene and protein expression of
transcription factor C/EBP, involved in
energy metabolism.
Park et al. [78] Intrauterine growth restriction in
Sprague Dawley rats at day 18 of
pregnancy.
Male offspring pancreatic islets at
fetal (21 d gestation), 2 weeks and 6
months of age.
Pdx1 histone H3 and H4
hypermethylation and
hypoacetylation with age. Extensive
DNA methylation at CpG sites in the
proximal promoter.
Reduced Pdx1 gene expression in islets
likely contributing to impaired -cell
development and function and development
of diabetes in adulthood.
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f Methyl-CpG binding domain proteins (MBDs) to the methyl-
ted CpG. The binding of MBDs recruit other factors to the DNA
hat contribute to alteration of chromatin structure and blocking
ccess of transcription factors to the DNA for initiation of tran-
cription [91]. Some of the factors that contribute to the silencing
f genes following methylation of CpG sites include the co-
epressor protein (Sin3a), ATP-dependent remodeling protein
NuRD) and histone deacetylase (HDAC), which all interfere
ith transcription factors and the binding of RNA Polymerase
I to the promoter sequence. Non-CpG methylation (methylation
t cytosine bases outside of a CpG site) has also been observed
nd although less is known about the consequences of non-CpG
ethylation on gene expression some evidence suggests it may
ffect transcriptional processes such as RNA splicing, alternative
ranscripts and alternative promoters [92–94].
.2.  DNA  methylation  and  metabolic  disease
Several studies have focused on functionally important
etabolic genes to link epigenetic modifications with the devel-
pment of insulin resistance or type 2 diabetes. A major
andidate identified that undergoes epigenetic regulation and
as been implicated in type 2 diabetes is the master regulator
f mitochondrial biogenesis, peroxisome proliferator activated
eceptor-  (PPAR) co-activator-1 (PGC-1). Epigenetic reg-
lation of PGC-1  has been shown in the skeletal muscle [72]
nd pancreatic islets of humans with type 2 diabetes [71] and
n the liver of patients of non-alcoholic fatty liver disease [95].
arres and colleagues showed in the skeletal muscle of type 2
iabetes patients that methylation of CpG at -260 in the promoter
f the PGC-1  gene was hypermethylated, and this hypermeth-
lation correlated with reduced PGC-1  gene expression [72].
mportantly, hypermethylation of the PGC-1  promoter was
ene-specific since no differences in DNA methylation were
etected on the flanking genes. Interestingly, non-CpG methyl-
tion was also found to be elevated in the PGC-1  gene and
as acutely increased in human myotubes following treatment
ith TNF-  or free fatty acids [72] and provides a possible
unctional link between epigenetic modification and disease phe-
otype. Furthermore, using siRNA knock down of each DNMT
soform (1, 3a and 3b) in primary human myocytes, Barres and
olleagues identified DNMT3b as the isoform responsible for
almitate-induced methylation of PGC-1  [72].
Transgenerational transmission of epigenetic marks was first
escribed by Morgan and colleagues using the Avy-dependent
oat color mouse [96]. The Avy allele carries an intra-cisternal
 particle retrotransposon (IAP) with a cryptic promoter region
pstream of the agouti gene. The transcription of the agouti gene
riginates from the IAP resulting in constitutive expression of
he agouti protein, and the mice display a yellow agouti phe-
otype. Morgan and colleagues showed that methylation of the
AP region was associated with a wild-type coat color pheno-
ype, even though the mice were genetically agouti. In addition,
arents that displayed an agouti phenotype were more likely to
roduced agouti offspring, while parents displaying a wild-type
henotype were more likely to produced offspring of wild-
ype phenotype. This study suggested that DNA methylation
h
f
f
numan Wellness 2 (2013) 1–11
arks could be transmitted across multiple generations [96].
ther studies utilizing the Avy mouse showed that methyl sup-
lemented diets during pregnancy were sufficient to increase
ethylation of the Avy-allele and produce offspring of pseudo-
gouti appearance regardless of the parents phenotype [97,98],
nd this phenytope was then passed on to the F2 generation [98].
hese were the first studies showing that manipulations of the
aternal condition could cause epigenetic modifications in the
ffspring and produce a variety of phenotypic outcomes even
hough the offspring were genetically identical.
Multiple studies have since shown that other manipulations
o the maternal condition can also impact on DNA methyl-
tion status of the offspring. For example, maternal dietary
rotein restriction in pregnant rats has been shown to reduce
romoter methylation in the offspring liver of the nuclear recep-
ors peroxisome proliferator activated receptor   (PPAR) and
lucocorticoid receptor (GR), of which the target genes play
ey roles in glucose and lipid metabolism [99]. Indeed, these
ethylation changes were associated with changes in target gene
xpression and glucose and lipid metabolism [99]. Furthermore,
ypomethylation of PPAR  and GR was also observed in the
2 generation, supporting the premise that epigenetic changes
an be inherited and thus increased susceptibility to metabolic
isease may also be transmitted across generations through epi-
enetic mechanisms [99]. Importantly, in a separate study in rat
ffspring of protein restricted dams, hypomethylation of GR in
he liver was associated with reduced DNMT1 expression and
inding to the GR promoter [81]. In a more recent study by the
ame group, they found that a 25% increase in dietary energy
rom conception in F0 female rats induced altered methylation
f specific CpG islands in the phosphoenolpyruvate carboxyk-
nase (PEPCK) gene in the liver of the F1 generation along
ith increased DNMT3a expression [100]. PEPCK is the rate-
imiting enzyme for gluconeogenesis in the liver, and altered
ethylation status of PEPCK in the F1 generation was associ-
ted with increased mRNA levels of the PEPCK gene, indicative
f increased liver gluconeogenesis [100]. Interestingly, when the
5% increase in dietary energy was maintained throughout the
ife span of the F2 and F3 generations, some but not all epi-
enetic changes observed in the F1 generation were observed
n successive generations. Therefore, DNA methylation marks
ay only be maintained into later generations depending on the
pecific CpG site, which may be dependent on location within
he gene and recruitment of other binding factors.
Since the PGC-1  promoter has been shown to be hyper-
ethylated in skeletal muscle and pancreatic islets of patients
ith type 2 diabetes, an important question now is whether
hese marks were established during fetal development? Studies
n humans have shown that maternal BMI positively corre-
ated with PGC-1  methylation in umbilical cord DNA [101],
hile others showed in men that were born small and hence
ere growth restricted during gestation that PGC-1  was hyper-
ethylated in skeletal muscle [70]. However, in this study,ypermethylation of PGC-1  in the muscle had no apparent
unctional impact, and only following 5 days of high-fat diet
eeding was PGC-1  gene expression reduced compared with
ormal birth weight, age-matched controls on high fat diet [70].
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hese findings suggest that a second insult may be required to
nmask the consequences of epigenetic modifications on gene
xpression and phenotypic outcomes. Indeed, the health impli-
ations of an abnormal gestational milieu are more apparent
hen there is additional metabolic demand in postnatal life,
uch as accelerated growth during childhood, high fat diet or
ging [5,102].
.3.  Histone  modiﬁcation
Histone modifications include a variety of post-translational
odifications with the most prominent being acetylation/de-
cetylation and methylation/de-methylation of the lysine
esidues in the N-terminal tails. These modifications alter gene
ranscription by changing the confirmation of the chromatin
nto open or closed states and hence alter availability of gene
romoter regions to transcriptional machinery. Acetylation of
istones leads to an open chromatin confirmation and is regu-
ated by the enzymes histone acetyl transferase (HATs)/histone
eacetylase (HDACS) while methylation of histones promotes
 closed confirmation and is regulated by histone methyl trans-
erase (HMTs)/histone demethylase (HDM) [103,104].
In the developmental programming field, some early stud-
es identified histone modifications in rat offspring exposed to
teroplacental insufficiency during gestation with overall hyper-
cetylation of histone H3 in the liver at birth [105]. These
odifications were associated with specific changes in the
xpression of metabolic regulatory gene, PGC-1, and lipid
etabolism intermediate transporter gene, carnitine palmitoyl-
ransferase 1 (CPT1) along with site-specific hyperacetylation
f histone H3 lysine K9 in the promoter regions of these
enes [105]. More recent studies investigating maternal obe-
ity reported association of histone modifications in perinatal
rimate offspring with fatty liver disease [106], while oth-
rs have showed histone modifications in the PEPCK gene in
he liver associated with increased gluconeogenesis in neona-
al rat offspring of high-fat fed mothers [107]. Whether these
odifications are sustained into later life and ultimately con-
ribute to disease pathogenesis has yet to be determined.
evertheless, these findings have highlighted the possibility of
aternal-induced changes to offspring liver metabolism through
odifications to the histone code.
Much of the interest in developmentally induced alter-
tions in epigenetic marks and later disease development has
een focused on the liver with only a handful of studies
nvestigating histone modifications in skeletal muscle. It is
nown that skeletal muscle metabolic regulation is impaired
n growth restricted rats and humans, which is associated with
educed expression of the insulin responsive glucose trans-
orter 4 (GLUT4) [53–55]. These changes in GLUT4 expression
ave recently been shown to be mediated through histone de-
cetylation and di-methylation at sites in the GLUT4 gene
ausing co-repressor complex formation resulting in decreased
LUT4 transcription at birth that persists into adulthood [108].
nterestingly, the histone modifications that caused altered
LUT4 transcription were found to be in the absence of any
hanges to DNA methylation [108]. Others showed skeletal
d
e
b
ouman Wellness 2 (2013) 1–11 7
uscle-specific hyperacetylation of histones H3 and H4 in rats
xposed to maternal dietary protein restriction in the promoter
egion of CCAAT/enhancer-binding protein (C/EBPbeta) [109].
/EBPbeta regulates the expression of genes involved in energy
omeostasis and muscle development; however, the functional
onsequences for skeletal muscle metabolism and function were
ot further investigated.
Tissue-specific epigenetic modifications have also been
emonstrated in pancreatic islets in rats exposed to intrauter-
ne growth restriction. The pancreatic and duodenal homeobox
 (Pdx1) gene is a transcription factor essential for pancreatic
-cell development and function, and its expression was found
o be reduced in growth restricted rats at birth as well as in
dulthood and was associated with the onset of diabetes [78].
he functional outcomes were attributed to altered acetylation
nd methylation states of the H3 and H4 histones as well as
ypermethylation of the CpG island proximal to the promoter
f the Pdx1 gene [78]. These findings in the skeletal muscle
nd pancreas support a role for tissue-specific epigenetic mod-
fications in offspring induced by an altered maternal condition
nd their contribution to tissue-specific phenotype and disease
evelopment.
.4.  MicroRNA
MicroRNAs are small non-coding RNAs that can affect trans-
riptional processing of genes. Some studies have found that
icroRNAs may play a role in the regulation of DNA meth-
lation levels [73,74]. In one study, Dicer1 deficient mice, a
olecule involved in the generation of silencing microRNAs,
ere found to have reduce expression of a cluster of microRNAs-
90 which was associated with defects in DNA methylation and
educed expression of DNMT1, 3a and 3b isoforms [73].
Since the role of microRNAs in epigenetic regulation is an
merging concept in a relatively new field, few studies in devel-
pmental programming have investigated microRNA changes
n offspring development. One study performed a microarray in
he liver of rat offspring from mothers fed a high-fat diet and
eported that 23 microRNAs were reduced between 1.5 and 5-
old including microRNA-709, which is the most abundantly
xpressed microRNA in the liver [110]. Interestingly, methyl
pG binding protein 2 (MECP2) and MBD6 are major targets
or microRNA-709 and these findings provide a potential link
etween developmental programming and epigenetic modifica-
ions mediated through microRNA regulation.
.5.  Potential  therapeutic  strategies
Some studies have aimed at identifying interventions to pre-
ent adverse health outcomes for offspring exposed to poor
evelopmental conditions. Some have investigated the potential
enefits of improved nutrition after birth [111,112] while other
tudies have investigated the impact of exercise in the offspring at
ifferent ages [113–119]. These studies were performed in mod-
ls of fetal growth restriction and, to our knowledge, there have
een no studies aimed at offsetting the adverse consequences
f maternal high fat diet on offspring health. However, these
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ntervention studies provide important information that could
e applied to other adverse maternal conditions and the con-
equences for the offspring. A series of studies conducted in
he Wlodek laboratory investigated the potential of improving
ostnatal nutrition by cross-fostering rat offspring that were
rowth restricted in  utero  onto a healthy mother that produced
etter quality lactation [111,120]. Their major findings showed
hat improved postnatal lactation in small birth weight offspring
artially ameliorated the impaired glucose tolerance [111] and
ormalized pancreatic -cell deficits at 6 months of age. Oth-
rs reported that skeletal muscle mtDNA content at 15 and 20
eeks of age was partially rescued in rat offspring exposed to
aternal protein restriction throughout gestation and lactation,
hen weaned onto a control diet at 4 weeks of age compared
ith litter mates weaned onto a low protein diet [112].
Recently, the potential benefits of exercise training in the
ffspring have also generated interest in the developmental pro-
ramming field. Earlier studies in humans showed that regular
oderate exercise protected elderly people born of low birth
eight from glucose intolerance [118]. A more recent study
n humans showed that 9 days of intensive exercise training
mproved mitochondrial function in adult offspring of mothers
ith type 2 diabetes [119]. However, improvements in insulin
ensitivity were only observed in offspring from healthy moth-
rs [119]. It is possible that an intervention in early life when the
ffspring are undergoing rapid growth and development would
ore likely produce long lasting consequences to later health
utcomes. Indeed studies in rats exposed to maternal nutrient
estriction [115] during gestation and then exercised in the early
uvenile period demonstrated subtle metabolic improvements
nd increased insulin stimulated GLUT4 translocation to the
lasma membrane in adulthood [115]. Furthermore, in rat off-
pring exposed to uteroplacental insufficiency, early exercise
raining had a remarkable ‘reprogramming’ effect to normalize
ancreatic islet surface area and -cell mass at 6 months of age
113]. Finally, the impact of maternal exercise in mice and rats
rior to mating as well as throughout pregnancy and nursing
n adult offspring metabolic outcomes was recently reported by
arter and colleagues [121,122]. In both mice and rats, mature
ffspring of dams that exercised displayed improved whole body
etabolic phenotype as well as increased glucose disposal in
keletal muscle [121,122], representing a promising interven-
ion that may influence epigenetic mechanisms during birth that
ave significant impact on later metabolic health. Importantly,
ince the role of epigenetic reprogramming is a recent focus
n the field there have been no studies to determine whether
ny of the aforementioned interventions were associated with
n epigenetic mechanism and represents an important next step
n intervention studies.
.  Conclusion
Although currently sparse, there is a growing abundance
f literature to support epigenetic modifications as underly-
ng mechanisms to developmental programming with long-term
unctional consequences for disease development in adult life.
he current studies are limited in their interpretation, and manyuman Wellness 2 (2013) 1–11
f the findings demonstrate associations without confirming suf-
ciency or necessity for epigenetic modifications in later disease
evelopment. Furthermore, epigenetic regulation involves com-
lex protein-DNA interactions, presenting significant challenges
o experiment execution and data interpretation. Nevertheless,
pigenetic modifications will likely be the key players in the
nderlying mechanisms of developmental programming and
ill be fundamental to future research in this field.
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